Your browser is no longer supported. Please, upgrade your browser.
Settings
AAAP Advanced Accelerator Applications S.A. daily Stock Chart
AAAP [NASD]
Advanced Accelerator Applications S.A.
Index- P/E- EPS (ttm)-0.64 Insider Own- Shs Outstand43.24M Perf Week1.32%
Market Cap1.62B Forward P/E123.11 EPS next Y0.31 Insider Trans- Shs Float4.69M Perf Month-4.21%
Income-27.10M PEG- EPS next Q-0.14 Inst Own33.00% Short Float9.95% Perf Quarter22.47%
Sales117.10M P/S13.87 EPS this Y-24.00% Inst Trans5.30% Short Ratio3.89 Perf Half Y-2.82%
Book/sh7.07 P/B5.31 EPS next Y144.10% ROA-8.20% Target Price44.13 Perf Year7.38%
Cash/sh5.50 P/C6.83 EPS next 5Y- ROE-12.70% 52W Range23.50 - 40.92 Perf YTD40.32%
Dividend- P/FCF- EPS past 5Y- ROI-6.30% 52W High-8.58% Beta-
Dividend %- Quick Ratio6.60 Sales past 5Y26.40% Gross Margin76.50% 52W Low59.19% ATR1.09
Employees501 Current Ratio6.80 Sales Q/Q24.40% Oper. Margin-17.90% RSI (14)44.33 Volatility2.84% 2.56%
OptionableNo Debt/Eq0.05 EPS Q/Q2.50% Profit Margin-23.10% Rel Volume0.19 Prev Close37.55
ShortableYes LT Debt/Eq0.04 EarningsMar 23 BMO Payout- Avg Volume120.09K Price37.41
Recom2.20 SMA20-2.71% SMA50-1.17% SMA2009.19% Volume5,202 Change-0.37%
Dec-22-16Downgrade JMP Securities Mkt Outperform → Mkt Perform
Nov-29-16Downgrade Wells Fargo Outperform → Market Perform
Oct-18-16Initiated Wells Fargo Outperform
Dec-07-15Initiated JMP Securities Mkt Outperform $44
Dec-07-15Initiated Jefferies Buy $33
Dec-07-15Initiated Citigroup Buy $32
Dec-07-15Initiated Canaccord Genuity Buy $35
Apr-20-17 02:09PM  ETFs with exposure to Advanced Accelerator Applications SA : April 20, 2017 Capital Cube
Apr-10-17 01:40PM  ETFs with exposure to Advanced Accelerator Applications SA : April 10, 2017 Capital Cube
Apr-07-17 02:58PM  Advanced Accelerator Applications SA :AAAP-US: Earnings Analysis: Q4, 2016 By the Numbers : April 7, 2017 Capital Cube
12:28PM  Advanced Accelerator Applications SA :AAAP-US: Earnings Analysis: 2016 By the Numbers : April 7, 2017 Capital Cube
Mar-30-17 07:30AM  Advanced Accelerator Applications Signs Strategic Supply Agreement with University of Missouri for Lutetium 177 GlobeNewswire
Mar-25-17 12:01AM  Today's Strong Buys Breaking Out to New Highs Zacks
Mar-23-17 07:35PM  Edited Transcript of AAAP earnings conference call or presentation 23-Mar-17 2:00pm GMT Thomson Reuters StreetEvents +6.11%
07:30AM  Advanced Accelerator Applications Reports 23% Sales Growth for Fiscal 2016; Continued NETSPOT® Launch Success GlobeNewswire
07:07AM  Q4 2016 Advanced Accelerator Applications SA Earnings Release - Before Market Open
Mar-22-17 04:05PM  Investor Network Invites You to the Advanced Accelerator Applications Year-End 2016 Earnings Conference Call and Webcast Live on Thursday, March 23, 2017 Accesswire
Mar-20-17 12:46PM  Biotech firm says its closing in on the cancer that killed Steve Jobs MarketWatch
12:46PM  Biotech firm says its closing in on the cancer that killed Steve Jobs at MarketWatch
Mar-15-17 07:00AM  Advanced Accelerator Applications to Announce Full-Year 2016 Financial Results on March 23 GlobeNewswire
Mar-14-17 08:30AM  Calithera Biosciences (CALA) Rises: Stock Moves Up 19.3% Zacks
Mar-09-17 09:27AM  New Strong Buy Stocks for March 9th Zacks
Mar-06-17 07:00AM  Advanced Accelerator Applications Announces Presentation of Quality of Life Findings from NETTER-1 Phase III Study at ENETS GlobeNewswire
Mar-01-17 07:00AM  Advanced Accelerator Applications Announces Addition of NETSPOT® to National Comprehensive Cancer Network® Guidelines for Evaluation of NETs GlobeNewswire
Feb-13-17 08:15AM  Advanced Accelerator (AAAP) Catches Eye: Stock Jumps 5.4%
Jan-12-17 08:05AM  Advanced Accelerator Applications Announces New England Journal of Medicine Publication of Lutathera® NETTER-1 Phase III Results GlobeNewswire
Jan-11-17 12:30PM  ETFs with exposure to Advanced Accelerator Applications SA : January 11, 2017
Jan-09-17 07:00AM  Advanced Accelerator Applications CEO Provides Progress Report on Corporate Developments of 2016; Asserts Confidence in Ability to Address FDA Comments on Lutathera® NDA GlobeNewswire
Jan-04-17 07:00AM  Advanced Accelerator Applications to Present at 35th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-22-16 06:59AM  Advanced Accelerator Applications downgraded by JMP Securities
Dec-21-16 07:00AM  Advanced Accelerator Applications Receives Complete Response Letter from FDA for Lutathera®, an Investigational Treatment for Neuroendocrine Tumors GlobeNewswire -5.84%
Dec-15-16 07:00AM  Advanced Accelerator Applications Announces European Commission Approval of SomaKit TOC GlobeNewswire
Dec-12-16 07:45PM  Is Advanced Accelerator Application SA (ADR) (AAAP) a Good Stock to Buy? at Insider Monkey
Dec-08-16 07:00AM  Advanced Accelerator Applications Announces CMS Pass-Through Reimbursement Code for its First FDA Approved Drug NETSPOT® GlobeNewswire
Dec-06-16 01:40PM  Is Herc Holdings Inc. (HRI) Worthy of Your Portfolio? at Insider Monkey
Nov-30-16 08:45AM  Aclaris Therapeutics (ACRS) Worth Watching: Stock Up 7.5%
Nov-29-16 09:24AM  Advanced Accelerator Applications SA :AAAP-US: Earnings Analysis: Q3, 2016 By the Numbers : November 29, 2016
02:06AM  Edited Transcript of AAAP earnings conference call or presentation 28-Nov-16 9:30pm GMT
Nov-28-16 09:00AM  Investor Calendar Invites You to the Advanced Accelerator Applications Third Quarter 2016 Earnings Conference Call and Webcast Live on Monday, November 28, 2016 Accesswire -10.35%
08:30AM  IntelliPharmaCeutics (IPCI) Jumps: Stock Adds 5% in Session
07:34AM  Advanced Accelerator reports 3Q loss
07:07AM  Q3 2016 Advanced Accelerator Applications SA Earnings Release - Before Market Open
07:00AM  Advanced Accelerator Applications Reports 15.4% Sales Growth in the Third Quarter of 2016 and Feedback from the FDA for Lutathera®, an Investigational Treatment for Neuroendocrine Tumors GlobeNewswire
Nov-24-16 05:48PM  The Healthcare Gurus at Baker Bros. Advisors Were Buying These Stocks in Q3 at Insider Monkey
Nov-23-16 07:30AM  Advanced Accelerator Applications to Announce Third Quarter and Nine-Month 2016 Financial Results on November 28 GlobeNewswire
Nov-18-16 07:42AM  Is a Surprise in Store for Medtronic (MDT) in Q2 Earnings?
Nov-17-16 09:25AM  Patterson Companies (PDCO) Q2 Earnings: What's in Store?
09:14AM  Can Veeva Systems (VEEV) Pull a Surprise in Q3 Earnings?
08:52AM  Deere (DE) to Report Q4 Earnings: What's in the Cards?
Nov-15-16 08:25AM  Xencor (XNCR) Looks Good: Stock Adds 13.2% in Session
Nov-14-16 09:33AM  Why Concordia International (CXRX) Could Be Positioned for a Slump
Nov-11-16 08:35AM  Corcept (CORT) Looks Good: Stock Jumps 6.5% in Session
Nov-02-16 07:00AM  Advanced Accelerator Applications Announces Swiss Marketing Authorization for Two PET Diagnostic Products GlobeNewswire
Oct-28-16 09:30AM  Zacks.com featured highlights: Primo Water, Horizon Global, Hallador Energy and Advanced Accelerator Applications S.A.
Oct-27-16 08:46AM  Stay Ahead of Time: Buy 4 Stocks with Recent Price Strength
Oct-24-16 09:35AM  What Falling Estimates & Price Mean for Pacira Pharmaceuticals (PCRX)
Oct-18-16 08:00AM  Egalet Corporation (EGLT) in Focus: Stock Moves 9.5% Higher
Oct-17-16 07:00AM  Advanced Accelerator Applications Announces Positive EMA Opinion on Application for SomaKit TOC GlobeNewswire
Oct-12-16 09:18AM  7 Stocks to Buy with Solid Recent Price Strength
Oct-11-16 07:00AM  Advanced Accelerator Applications Announces Presentations on Lutathera® NETTER-1 Phase III and NeoBOMB1 at EANM GlobeNewswire
Oct-05-16 07:27PM  Advanced Accelerator Applications S.A. Announces Pricing of $150 Million Public Offering of American Depositary Shares GlobeNewswire
Oct-04-16 04:00PM  Advanced Accelerator Applications S.A. Announces Proposed Public Offering of American Depositary Shares GlobeNewswire
Sep-22-16 01:00PM  EMA Prematurely Announced Opinion on SomaKit TOC® Kit Application GlobeNewswire
Sep-20-16 07:00AM  Advanced Accelerator Applications Announces Revised EMA Review Timeline for Lutathera® GlobeNewswire +5.71%
Sep-19-16 08:35AM  Advanced Accelerator (AAAP) Worth Watching: Stock Jumps 6.2%
Sep-16-16 07:00AM  Advanced Accelerator Applications Announces Positive EMA Opinion on Application for SomaKit TOC Kit for Radiopharmaceutical Preparation of Gallium (Ga 68) Edotreotide for Gastroenteropancreatic Neuroendocrine Tumor Detection GlobeNewswire +6.15%
Sep-06-16 07:00AM  Advanced Accelerator Applications Announces Two Phase II Studies Evaluating 99MrhAnnexin V-128 Imaging in Cardiovascular and Cardio-Oncology Indications at University of Ottawa Heart Institute and Ottawa Hospital GlobeNewswire
Aug-31-16 07:00AM  Advanced Accelerator Applications Reports 24.4% Sales Growth in the Second Quarter of 2016 GlobeNewswire
Aug-03-16 07:00AM  Advanced Accelerator Applications Announces First Administration of NETSPOT at Holy Name Medical Center GlobeNewswire
Aug-02-16 07:00AM  Advanced Accelerator Applications Announces Clinical Trial Agreement with National Cancer Institute for Study of Lutathera in Patients with Inoperable Pheochromocytoma and Paraganglioma GlobeNewswire
Jul-26-16 07:00AM  Advanced Accelerator Applications Announces Opening of First U.S. Manufacturing Facility; Preparation for Anticipated Lutathera Launch GlobeNewswire
Jun-27-16 07:00AM  Advanced Accelerator Applications Announces FDA Priority Review for Lutathera GlobeNewswire
Jun-10-16 01:23PM  Advanced Accelerator Application SA (AAAP) Signs Another NETSPOT Supplier in Cardinal Health at Insider Monkey
07:00AM  Advanced Accelerator Applications Expands U.S. NETSPOT Supply Chain with Two Additional Radiopharmacy Networks GlobeNewswire
Jun-09-16 07:51AM  Cardinal Health to Prepare NETSPOT Doses for Advanced Accelerator Applications GlobeNewswire
Jun-08-16 05:16PM  Advanced Accelerator Application SA (ADR) (AAAP) Expands Pipeline With NeoBOMB1 at Insider Monkey
Jun-07-16 08:29AM  Advanced Accelerator Applications Announces Expansion of Theranostic Pipeline with NeoBOMB1 GlobeNewswire
Jun-02-16 07:00AM  Advanced Accelerator Applications Announces FDA Approval of NETSPOT (Somakit-TATE), a Kit for the Preparation of Gallium Ga 68 Dotatate for Neuroendocrine Tumor Detection GlobeNewswire
May-31-16 07:00AM  Advanced Accelerator Applications Reports 29.6% Sales Growth in the First Quarter of 2016 GlobeNewswire
May-26-16 11:00AM  Advanced Accelerator Applications Expands its Presence in Germany with Strategic Acquisition of Two Production Sites GlobeNewswire
07:00AM  Advanced Accelerator Applications Appoints Francois Nader, M.D., to Board of Directors GlobeNewswire
May-23-16 03:00AM  Advanced Accelerator Applications preparing for Lutathera launch by scaling up production in Ivrea, Italy GlobeNewswire
May-18-16 04:00AM  ITEL signs agreement with Advanced Accelerator Applications to commercialize F-18 radiopharmaceuticals in Southern Italy GlobeNewswire
May-11-16 08:39AM  ChemoCentryx (CCXI) Shows Strength: Stock Moves Up 42.4% -5.45%
May-05-16 01:04PM  ADVANCED ACCELERATOR APPLICATIONS S.A. Financials -5.00%
May-03-16 09:38AM  Advanced Accelerator Applications SA :AAAP-US: Earnings Analysis: 2015 By the Numbers
Apr-29-16 05:49PM  Edited Transcript of AAAP earnings conference call or presentation 29-Apr-16 3:00pm GMT
11:00AM  Advanced Accelerator Applications SA Earnings Call scheduled for 11:00 am ET today
07:07AM  Q4 2015 Advanced Accelerator Applications SA Earnings Release - Before Market Open
07:00AM  Advanced Accelerator Applications reports 26.8% sales growth in 2015 and continues to show significant clinical progress across both therapeutic and diagnostic platforms GlobeNewswire
Apr-22-16 07:00AM  Advanced Accelerator Applications to Announce Fourth Quarter and Year End 2015 Financial Results on April 29, 2016 GlobeNewswire
Mar-23-16 07:32AM  Advanced Accelerator Applications Opens Lutathera Expanded Access Program In U.S. to Eligible Patients And Announces Forthcoming NDA Filing to FDA and EMA at noodls
07:00AM  Advanced Accelerator Applications Provides Lutathera Update GlobeNewswire
Mar-02-16 09:35AM  Michael Castors Sio Capital Managements New Bets For This Quarter at Insider Monkey
Feb-25-16 07:00AM  Advanced Accelerator Applications Provides Update on Lutathera and Somakit GlobeNewswire
Jan-26-16 07:49AM  Zevacor to produce SomaKit-TATE doses for AAA Novel kit for the preparation of Ga-68 DOTATATE for neuroendocrine tumor detection at noodls
07:00AM  Zevacor to Produce SomaKit-TATE Doses for AAA GlobeNewswire
Jan-11-16 07:00AM  Advanced Accelerator Applications Signs Exclusive License Agreement With Johns Hopkins University to Develop PSMA Receptor Ligand in Prostate Cancer GlobeNewswire
Jan-10-16 07:00AM  Advanced Accelerator Applications to Present New Data From Lutathera NETTER-1 Phase 3 Study at 2016 Gastrointestinal Cancer Symposium (ASCO GI) GlobeNewswire
Jan-07-16 07:00AM  Advanced Accelerator Applications Acquires the IDB Group GlobeNewswire
Dec-10-15 07:00AM  Advanced Accelerator Applications Reports 37% Growth in Sales for the Third Quarter of 2015 and 32% Growth in Sales for the First Nine Months of 2015 GlobeNewswire
Nov-13-15 03:56PM  Nasdaq Welcomes Advanced Accelerator Applications S.A. (Nasdaq: AAAP) to The Nasdaq Stock Market GlobeNewswire
Nov-12-15 10:00AM  Advanced Accelerator Applications S.A. (Nasdaq: AAAP) to Ring the Nasdaq Stock Market Opening Bell in Celebration of Its IPO GlobeNewswire
Nov-11-15 02:29PM  Why Are These Four Stocks Hot on The Market on Wednesday? at Insider Monkey
01:05PM  4 New Issues Make Today The Hottest IPO Day In Months
Nov-10-15 07:09PM  Advanced Accelerator Applications S.A. Announces Pricing of Initial Public Offering Accesswire
07:09PM  Advanced Accelerator Applications S.A. annonce la fixation du prix des ADS offerts dans le cadre de son introduction en bourse sur le Nasdaq Accesswire
Advanced Accelerator Applications SA is a radiopharmaceutical company that develops, produces and sells molecular nuclear medicine (MNM), diagnostic and therapeutic products. The Company's lead therapeutic candidate, Lutathera, is being developed for the treatment of midgut neuroendocrine tumors (NETs). The Company has a portfolio of six diagnostic positron emission tomography (PET) and single-photon emission computed tomography (SPECT) products. Its products in clinical development include Lutathera, Somakit and Annexin V-128. The Company's commercial products include Gluscan /Gluscan 500/Barnascan, IASOflu, IASOdopa, IASOcholine, MIBITEC/Adamibi and Leukokit. Lutathera is a solution of a Lu-177-labeled analogue of somatostatin, a hormone that acts as a regulator of the endocrine system. Somakit is the Company's companion PET diagnostic product candidate for Lutathera. Annexin V-128 is a SPECT diagnostic candidate for the assessment of apoptotic and necrotic processes.